Election 2019: T1D research remains a winner
JDRF would like to congratulate all those MPs that were elected in the 2019 Federal Election. We would like to congratulate the Morrison Liberal National Coalition for their return to Government and wish them well into the future.
Given the partisan nature of Australian politics, with two major parties, there is an inherent challenge for any advocacy group or charity. This is, which side of politics are more likely to support you? At JDRF we have remained rigorously bi-partisan in our approach to politics. This means that we ensure to maintain our relationships both sides of the political aisle. We work extremely hard to ensure regardless of party allegiance or faction, all of Australia’s federal politicians understand the realities of living with T1D and why research holds the key.
It is down to this hard work that we went into the election knowing both major parties knew about the impact of the CRN and why its continuation was key to the 120,000 Australians living with T1D. So much so in fact, that in January the Morrison government confirmed over $50m for T1D research, including $25m for the CRN.
And while it is outstanding that the work of the CRN can continue, our work with government does not stop there. Over the coming months, we’ll be working with the community, researchers and advocates to ensure we keep raising awareness with decision makers in Canberra of the issues facing people living with T1D.
And finally, some of our youngest advocates, and aspiring artists, have written their own thanks, which you can check out below.
Report: Aussie adults with type 1 diabetes unable to access life-changing technology due to high cost
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]
T1D Research Roundup: March 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Monash University researchers crack the […]
COVID-19 Vaccines and T1D: Answering Your Questions
Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines beginning to be offered to people with T1D, we’ve gathered all the information you need to […]
Top 10 T1D Research Breakthroughs of 2020
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission to cure, treat and prevent T1D – including new insights into what causes the disease, some incredible results from prevention therapies, and the launch of […]